Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.

Robin SchmitzMohamed A AdamDan G Blazer

Published in: World journal of surgical oncology (2019)

This national study suggests that traveling to high-volume centers for the treatment of RPS confers a significant short-term and long-term survival advantage, supporting centralized care for RPS.

Keyphrases

healthcare
quality improvement
palliative care
high grade
pain management
replacement therapy
smoking cessation